Anamorelin Shows Increased Survival in Non-Small Cell Lung Cancer
October 9th 2015Researchers discovered that the use of anamorelin among patients with advanced non-small cell lung cancer considerably helped more patients stabilize or gain lean body mass, a factor that consequently enables patients with cachexia to survive longer.